Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Shares Outstanding (2018 - 2023)

Historic Shares Outstanding for Neurogene (NGNE) over the last 4 years, with Q3 2023 value amounting to $8.8 million.

  • Neurogene's Shares Outstanding changed N/A to $8.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $8.8 million, marking a year-over-year change of. This contributed to the annual value of $38.0 million for FY2019, which is 6143.2% up from last year.
  • Per Neurogene's latest filing, its Shares Outstanding stood at $8.8 million for Q3 2023.
  • Neurogene's 5-year Shares Outstanding high stood at $41.9 million for Q3 2020, and its period low was $8.6 million during Q1 2023.
  • In the last 3 years, Neurogene's Shares Outstanding had a median value of $25.8 million in 2019 and averaged $25.8 million.
  • Per our database at Business Quant, Neurogene's Shares Outstanding changed by 0.0% in 2019 and then soared by 6351.25% in 2020.
  • Neurogene's Shares Outstanding (Quarter) stood at $38.0 million in 2019, then rose by 10.21% to $41.9 million in 2020, then tumbled by 78.97% to $8.8 million in 2023.
  • Its last three reported values are $8.8 million in Q3 2023, $8.8 million for Q2 2023, and $8.6 million during Q1 2023.